AEMD
Aethlon Medical, Inc.
0.76
2 x 0.54
2 x 0.87
bid
ask
-
0.07
8.19%
2 @ 08:33 AM
0.76 +0.00 (0.15%)
| Ytd | -72.71% | |
| 1y | -93.59% |
0.65
day range
0.80
0.65
52 week range
27.40
| Open | 0.70 | Prev Close | 0.82 | Low | 0.65 | High | 0.80 | Mkt Cap | 1.79M |
| Vol | 444.88K | Avg Vol | 631.28K | EPS | -10.61 | P/E | N/A | Forward P/E | -0.86 |
| Beta | 1.75 | Short Ratio | 0.98 | Inst. Own | 3.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 2.00 | 200-d Avg | 3.28 | 1yr Est | 3.85 |
| Income Statement | |||
| Operating Expenses | 1.93M | ||
| Selling, General and Administrative Expense | 698.02K | ||
| Operating Income | -1.93M | ||
| Interest Expense | 14.37K | ||
| Net Income | -1.88M | ||
| Net Income Common Stock | -1.88M | ||
| Net Income Common Stock (USD) | -1.88M | ||
| Consolidated Income | -1.88M | ||
| Earnings per Basic Share | 0.40 | ||
| Earnings per Basic Share (USD) | 0.40 | ||
| Earnings per Diluted Share | 0.40 | ||
| Earning Before Interest & Taxes (EBIT) | -1.87M | ||
| Earning Before Interest & Taxes (USD) | -1.87M | ||
| Weighted Average Shares | 673.95K | ||
| Weighted Average Shares Diluted | 673.95K | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.13M | ||
| Cash and Equivalents (USD) | 5.13M | ||
| Current Assets | 5.57M | ||
| Property, Plant & Equipment Net | 664.64K | ||
| Total Assets | 6.33M | ||
| Debt Current | 336.72K | ||
| Total Debt | 336.72K | ||
| Current Liabilities | 1.45M | ||
| Total Liabilities | 1.45M | ||
| Accumulated Retained Earnings (Deficit) | -175.11M | ||
| Accumulated Other Comprehensive Income | -32.70K | ||
| Shareholders Equity | 4.89M | ||
| Shareholders Equity (USD) | 4.89M | ||
| Assets Non-Current | 763.57K | ||
| Total Debt (USD) | 336.72K | ||
| Trade and Non-Trade Payables | 452.80K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 154.31K | ||
| Net Cash Flow from Financing | -196.50K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.93M | ||
| Capital Expenditure | -2.05K | ||
| Issuance (Purchase) of Equity Shares | -1.09M | ||
| Net Cash Flow from Investing | -2.05K | ||
| Net Cash Flow from Operations | -1.75M | ||
| Effect of Exchange Rate Changes on Cash | 19.21K | ||
| Share Based Compensation | 61.22K | ||